DE

EPO: claims directed to the use of a product produced by a process

Recently, the Technical Boards of Appeal had to decide on a claim under Article 84 EPC (clarity) which comprises process and product features (T 0081/14). More specifically, the claim being at stake concerned the use of a sintered cemented carbide body obtained according to a defined method for the production of a cutting tool.

The Board pointed out that the definition of a product is normally done by means of the structural features of the product. A definition in terms of the process of manufacture (“product-by-process definition”) is reserved for cases wherein a definition in terms of structural features is not possible. This principle is well established in the case law for a claim which is directed to a product (“product-by-process claims”).

In contrast thereto, the present claim is not directed to a product but to the use of a product which is equivalent to a claim directed to a process for the production of a cutting tool using the sintered cemented carbide body.

In this respect the Board stated that there is no reason to make the principles underlying the assessment of the clarity of product features dependent on the fact that said product features appear in a claim directed to a product or in a claim directed to a method.

Consequently, the Board decided that when considering the definition of a product in terms of its production process the principles developed in the jurisprudence for the “product-by-process claims” are in general to be applied, also in the case of a claim directed to the use of that product.

More articles from Dr. Raphael Bösl

The “Druckexemplar” determines the extent of protection conferred by a European patent

Dr. Raphael Bösl

Restoration of the Right of Priority under the PCT – different “Criterion for Restoration” before the USPTO and the EPO

Dr. Raphael Bösl

License Fees for a Compulsory License – Isentress II – German Federal Patent Court

Dr. Raphael Bösl

Follow-up: Preliminary Injunction confirmed by the German Federal Supreme Court in a Compulsory License Proceedings concerning a Medicament against AIDS

Dr. Raphael Bösl

Preliminary Injunction confirmed by the German Federal Supreme Court in a Compulsory License Proceedings concerning a Medicament against AIDS

Dr. Raphael Bösl

EPO clarifies practice in the area of plant and animal patents

Dr. Raphael Bösl

Urgent Notice of the Federal Patent Court: Preliminary Injunction issued in a Compulsory License Proceedings concerning “Isentress” (raltegravir against AIDS)

Dr. Raphael Bösl

EPO stays all proceedings in which the invention is a plant or animal obtained by an essentially biological process

Dr. Raphael Bösl

Communication from the Chairmen of the UPC Preparatory Committee and the EPO Select Committee dealing with the Unitary Patent of July 1, 2016

Dr. Raphael Bösl

Functional Features – Essential Features: A New Perspective under Article 84 EPC

Dr. Raphael Bösl

Plant Patent Protection and Plant Variety Protection – Two Independent IP Rights?

Dr. Raphael Bösl

A pitfall to supplement information incorporated by reference under the EPC

Dr. Raphael Bösl

EPO: claims directed to the use of a product produced by a process

Dr. Raphael Bösl

Enlarged Board of Appeal of the EPO decided on Clarity – expected decision now issued (G 3/14)

Dr. Raphael Bösl

Deautomation is not per se Inventive – an Exemption from the Rule under the EPC

Dr. Raphael Bösl

Four Step Approach in Determining Sufficiency of Disclosure of a Parameter under the EPC

Dr. Raphael Bösl

Refocus on the Interpretation of “Undue Burden” for the Determination of the Scope of Protection under the EPC

Dr. Raphael Bösl

Functional Definition of Compounds in Use Claims – Different Decisions in Germany and “Europe”

Dr. Raphael Bösl